# Acetylsalicylic Acid Versus Placebo as an add-on Treatment to Local Non-steroidal Anti-inflammatory Drug for the Management of Thrombotic Episodes in Superficial Venous Malformations in Children Aged 6 to 17 Years.

> **NCT07663825** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University Hospital, Tours** · enrollment: 34 (estimated)

## Conditions studied

- Venous Malformation, Low Flow
- Venous Malformations

## Interventions

- **DRUG:** AAS at anti-inflammatory doses from 3 days to 14 days.
- **DRUG:** Placebo from 3 days to 14 days.
- **DRUG:** Application of Diclofenac gel 1% twice a day

## Key facts

- **NCT ID:** NCT07663825
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2030-09
- **Final completion:** 2030-10-31
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07663825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07663825, "Acetylsalicylic Acid Versus Placebo as an add-on Treatment to Local Non-steroidal Anti-inflammatory Drug for the Management of Thrombotic Episodes in Superficial Venous Malformations in Children Aged 6 to 17 Years.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07663825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*